Skip to main content

Increasing clinical trial diversity

Pharma has turned its attention to health equity with razor-sharp focus in recent years. A new wave of strategies are beginning to flood the industry, including better approaches to recruiting diverse populations, attempts to overcome negative perceptions of research and efforts to take trials directly to patient communities.

included in this trendline
  • AZ oncology chief says AI can help solve cancer’s ‘ZIP code lottery’ as health disparities persist
  • Inside J&J’s strategy to de-gender clinical trials
  • Takeda plots ‘unprecedented patient diversity’ for psoriasis drug that could compete with BMS
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.